漢方薬市場：効能／治療目的別、形態別、供給源別、流通チャネル別、地域別、2026-2032年

漢方薬市場の評価-2026-2032

消費者意識の高まりと伝統医療促進への投資の増加が、ハーブ薬の採用を後押ししています。そのため、アーユルヴェーダやウナニの教えに基づいて自然に調合された医薬品への需要が高まり、市場規模は2024年に1,910億6,000万米ドルを突破し、2032年には約6,523億米ドルの評価額に達します。

これに加えて、アロパシー医薬品の潜在的な悪影響とハーブ医薬品の利点に対する意識の高まりが、ハーブ医薬品の採用に拍車をかけています。医薬品やサプリメントを含む様々な産業でハーブ医薬品の採用が増加しており、2026年から2032年にかけてCAGR 18.30%で市場が成長することを可能にしています。

漢方薬市場定義/概要

漢方薬は、植物の根、茎、葉、花、種子などから抽出され、健康増進や病気の治療に用いられます。人気のあるハーブには、イチョウ、高麗人参、ショウガ、ウコン、カモミールなどがあります。地元では何世紀にもわたって、これらの植物を人間や動物の病気に効く薬の調合に使ってきました。

漢方薬の用途と応用範囲は広く、健康状態や健康増進の目標も多岐にわたる。ハーブ療法は一般的に、インフルエンザ、風邪、消化器系の不調、頭痛、筋肉痛などの急性疾患に伴う症状を緩和するために使用されます。また、関節炎、アレルギー、心血管疾患、精神疾患などの慢性疾患にも用いられます。さらに、ヘルスケアは、免疫機能、ストレス管理、解毒、全体的な活力をサポートし、予防医療において重要な役割を果たしています。ハーバル製剤は、希望する治療効果や使用するハーブの特性によって、経口投与、局所投与、吸入投与が可能です。臨床研究では、様々な生薬の抗がん活性が示されています。このセクションでは、特定のがん種に対する抑制効果に基づいて、これらの医薬品の臨床使用を分類します。

伝統医学のハーブであるイチョウは、特に認知症や間欠性跛行の治療において、循環障害を治療し、記憶力を高めることが示されています。カバカバは気分を高めるハーブで、不安、不眠、神経障害の治療に役立つ可能性があります。ただし、カバは肝臓障害を引き起こす可能性が懸念されています。ノコギリヤシは、米国で200万人以上の男性が前立腺肥大症（BPH）の治療に使用しています。セントジョーンズワートは抗うつ作用で知られています。

新興諸国における天然医薬品の需要拡大は、漢方薬市場の成長をどのように促進するか？

新興諸国では、訓練を受けた医師や薬剤師の代わりに使用されることが多いため、ちょっとした病気の治療には漢方薬が欠かせないです。これらの医薬品は未加工のまま乾燥させ、お茶、カプセル、錠剤、軟膏、湿布などにして、体内の治癒や外傷の治療に使われます。新興経済諸国では規制が最小限に抑えられているため、これらの国々では様々な病気に生薬が使用されており、この業界は今後数年で急成長すると予想されています。

eコマースにおける生薬製品販売の増加は、オンライン購入体験の向上、ターゲットを絞ったマーケティング、オンライン教育によるところが大きいです。アマゾンのようなオンライン販売業者は、ハーブ製品のポートフォリオを開発し、特定の条件や要件に基づいてカスタマイズされたリストのためのライブチャットオプションやウェルネスツールを提供しています。この動向はオンラインショッピング体験の向上に起因しており、これが市場の成長を後押ししています。

COVID-19パンデミックの間、封鎖と社会的距離を置く措置により、漢方薬の消費者需要が急増しました。アーユルヴェーダ・サプリメントや漢方薬を含む天然・有機製品へのシフトや、ストレスや不安レベルの管理に植物薬が有効であるという認識の高まりが市場成長に寄与しました。

ヘルスケア相互運用性への政府投資の増加は、ヘルスケア製品・サービスの採用を促進しています。これらの資金は、患者の治療成果を改善し、シームレスなデータ交換を促進し、ヘルスケアITの技術革新を刺激することを目的としています。ヘルスケア支出の増加とインフラの進歩は、漢方薬を含むケア提供サービスの拡大を支えています。これにより、漢方薬の主流ヘルスケアへの統合が促進され、自然療法や代替療法を求める消費者の需要に応えることができます。

漢方薬のガイドラインの統一性の欠如は市場成長を抑制するか？

漢方薬市場は、国によって規制の枠組みが異なるため、大きな制約に直面しています。ハーブ製品の輸入、製造、表示に関するガイドラインの統一性の欠如は、サプライヤーや製造業者の市場参入とコンプライアンスを複雑にしています。このような断片的な規制状況は、運営コストを増加させるだけでなく、企業が多様な要件や基準をナビゲートするため、市場拡大の妨げにもなっています。

生薬の安全性、有効性、品質に関する懸念は、もう一つの足かせとなります。ハーブ成分の科学的検証や標準化された試験プロトコルが限られているため、消費者やヘルスケア従事者の間で不確実性が生じることが多いです。確固とした証拠に基づく調査と規制当局の監視がなければ、ハーブ製品に対する信頼と受容の確立は困難となり、より広範な採用と市場成長の妨げとなります。

また、自然療法への関心が高まっているにもかかわらず、紹介制度の欠如、不十分な情報システム、調整されていないヘルスケア政策などの問題により、ハーブ薬の主流ヘルスケアシステムへの統合は遅れています。

生薬市場の成長を妨げているのは、原材料の不足と輸出原料のコスト上昇、そして合成原料やプロバイオティクスが強力な競争相手となっている製品代替です。また、疑似漢方製品の入手可能性も大きな課題となっています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 漢方薬市場：形態別

• 錠剤とカプセル
• 粉末
• カプセルと錠剤
• シロップ剤
• エキス剤

第5章 生薬市場：供給源別

• 葉
• 根と樹皮
• 植物全体と果実

第6章 漢方薬市場：流通チャネル別

• 病院
• 小売薬局
• eコマース

第7章 漢方薬市場：適応症／治療用途別

• 消化器系の健康
• 免疫サポート
• 呼吸器の健康
• 心臓血管の健康
• 関節と筋骨格系の健康
• ストレス管理／メンタルヘルス

第8章 地域分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第9章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第10章 競合情勢

• 主要企業
• 市場シェア分析

第11章 企業プロファイル

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Novartis International AG
• Bayer AG
• Pfizer Inc.
• GlaxoSmithKline plc.
• Sanofi S.A.
• Merck & Co., Inc.
• Eli Lilly and Company
• Johnson & Johnson
• Nestle S.A.
• Herbalife International of America, Inc.
• Amway Corporation
• Nature's Sunshine Products, Inc.
• Dabur India Ltd.
• Himalaya Global Holdings Ltd.

第12章 市場展望市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第13章 付録

• 略語リスト
• 出典と参考文献

Herbal Medicine Market Valuation - 2026-2032

The rise in consumer awareness and increased investments in promoting traditional medicine are propelling the adoption of herbal medicine. Thus, the rising demand for naturally prepared medicines based on Ayurvedic and Unani teachings has surged which is driving the market size surpass USD 191.06 Billion valued in 2024 to reach a valuation of around USD 652.3 Billion by 2032.

In addition to this, the increasing awareness of the potential negative impacts of allopathic medicines and the advantages of herbal medicinal products are spurring up the adoption of Herbal Medicine. The increasing adoption of herbal medicinal preparations has surged in various industries, including pharmaceuticals and supplements is enabling the market grow at a CAGR of 18.30% from 2026 to 2032.

Herbal Medicine Market: Definition/ Overview

Herbal medicines, derived from plants' roots, stems, leaves, flowers, or seeds, are used to improve health and treat illnesses. Popular herbs include gingko, ginseng, ginger, turmeric, and chamomile. Local communities have used these plants for centuries to prepare medicines for human and animal diseases.

The uses and applications of herbal medicine are extensive, spanning a wide range of health conditions and wellness goals. Herbal remedies are commonly used to alleviate symptoms associated with acute ailments such as flu, colds, digestive upset, headaches, and muscle pain. They are also employed for chronic conditions like arthritis, allergies, cardiovascular disease, and mental health disorders. Additionally, Herbal Medicine plays a crucial role in preventive healthcare, supporting immune function, stress management, detoxification, and overall vitality. Herbal preparations can be administered orally, topically, or through inhalation, depending on the desired therapeutic outcome and the specific properties of the herbs used. Clinical studies show a spectrum of anticancer activities from various herbal medicines. This section categorizes the clinical use of these medicines based on their suppressive effect on specific cancer types.

Ginkgo, a traditional medicine herb, has been shown to treat circulatory disorders and enhance memory, particularly in treating dementia and intermittent claudication. Kava kava, a mood-enhancing herb, may help treat anxiety, insomnia, and nervous disorders. However, there is concern that kava may cause liver damage. Saw palmetto, used by over 2 million men in the US, is used for treating benign prostatic hyperplasia (BPH). St. John's wort is known for its antidepressant effects.

How will Growing Demand for Natural Medicines in Developing Countries Drive the Growth of the Herbal Medicine Market?

Herbal medicines are crucial in developing countries for treating minor ailments, as they are often used in place of trained doctors or pharmacists. These medicines are unprocessed, dried, and used in teas, capsules, pills, salves, and poultices for internal healing and external injuries. Due to minimal regulations in developing economies, the industry is expected to grow rapidly in the coming years, as herbal medicines are used for various ailments in these countries.

The rise in herbal medicinal product sales in e-commerce is largely due to improved online purchase experiences, targeted marketing, and online education. Online distributors like Amazon have developed portfolios for herbal products, offering live chat options and wellness tools for customized lists based on specific conditions and requirements. This trend is attributed to improved online shopping experiences, this is bolstering the growth of the market

During the COVID-19 pandemic, consumer demand for herbal medicines surged due to lockdowns and social distancing measures. This shift towards natural and organic products, including Ayurveda supplements and herbal medicines, and increased awareness of botanicals' benefits in managing stress and anxiety levels contributed to market growth.

Increasing government investments in healthcare interoperability are driving the adoption of healthcare products and services. These funds aim to improve patient care outcomes, facilitate seamless data exchange, and stimulate innovation in healthcare IT. Increased healthcare expenditure and infrastructure advancements support the expansion of care delivery services, including herbal medicines. This promotes the integration of herbal medicinal products into mainstream healthcare practices, meeting consumer demand for natural and alternative treatments.

Will Lack of Uniformity in Guidelines of Herbal Medicine Restrain Its Market Growth?

The herbal medicine market faces significant constraints due to varying regulatory frameworks across different countries. Lack of uniformity in guidelines for importing, manufacturing, and labeling herbal products complicates market access and compliance for suppliers and manufacturers. This fragmented regulatory landscape not only increases operational costs but also impedes market expansion as companies navigate diverse requirements and standards.

Concerns regarding the safety, efficacy, and quality of herbal medicines pose another restraint. Limited scientific validation and standardized testing protocols for herbal ingredients often lead to uncertainty among consumers and healthcare practitioners. Without robust evidence-based research and regulatory oversight, establishing trust and acceptance in herbal products becomes challenging, hindering broader adoption and market growth.

Also, despite increasing interest in natural therapies, the integration of herbal medicines into mainstream healthcare systems is slow due to issues like lack of referral mechanisms, inadequate information systems, and uncoordinated healthcare policies.

The growth of the herbal medicine market is hindered by a shortage of raw materials and increased costs of exported ingredients, as well as product substitution, with synthetic ingredients and probiotics being strong competitors. The availability of pseudo-herbal products also poses a significant challenge.

Category-Wise Acumens

Which Factors Contributing Tablets & Capsules Segment Dominance in Herbal Medicine Market?

The tablets & capsules segment dominates the herbal medicine market due to the availability of various herbal medicines in capsules and tablets. With an increasing number of prescriptions mentioning herbal products, this segment is expected to remain dominant in the pharmaceutical industry during the forecast period.

Tablets and capsules allow for precise dosing of herbal extracts and active ingredients, ensuring consistency in therapeutic effects. This standardized format appeals to both consumers and healthcare providers seeking reliable and predictable outcomes. They have longer shelf life compared to liquid formulations, enhancing product stability and reducing wastage, benefiting manufacturers and retailers in inventory management and product availability.

Many consumers perceive tablets and capsules as more professional and medically acceptable forms of herbal medicine. This perception contributes to their popularity and widespread acceptance in the market.

Advancements in formulation technologies have enhanced the effectiveness, stability, and bioavailability of herbal ingredients in tablet and capsule formats, enhancing nutrient absorption and enhancing the delivery of herbal compounds, thus increasing their acceptance among health-conscious individuals.

Which Factors Enhance the Use of Leaves-Based Herbal Medicine?

Leaves segment is currently dominating in Herbal Medicine Market. The therapeutic properties of leaves, including their antioxidant, anti-inflammatory, and detoxifying effects, have fueled their increasing use in herbal remedies. Rich in bioactive compounds like polyphenols, flavonoids, and essential oils, leaves appeal to health-conscious consumers seeking natural alternatives.

The versatility of leaves allows for their incorporation into various herbal formulations, such as teas, extracts, tinctures, and topical preparations, addressing a wide range of health needs. This adaptability enhances their presence and dominance in the herbal medicine market.

Leaves have been used in traditional medicine systems for centuries, establishing trust and knowledge among consumers. Cultural practices and historical use continue to popularize leaves-based herbal remedies in modern healthcare. They are versatile and easy to prepare, making them suitable for consumption in teas, extracts, and dried formulations. Their mild flavors and textures make them ideal for dietary supplements and culinary applications.

Additionally, rising consumer awareness of the benefits of plant-based diets and holistic wellness practices has boosted the demand for leaves-based herbal products. This growing interest is driving market expansion and solidifying the leaves segment's leadership in the herbal medicine industry.

Country/Region-wise Acumens

Will Growing Demand for Natural And Plant-Based Therapies in Europe Mature Herbal Medicine Market?

Europe dominates the herbal medicine market due to several key factors. The region benefits from a rising geriatric population and increasing prevalence of chronic diseases, prompting a growing demand for natural and plant-based therapies as alternatives or complements to conventional medicine. This demographic shift has bolstered the adoption of herbal remedies, driving market expansion.

Increasing awareness of the benefits of herbal remedies and rising consumer preference for sustainable products. The European herbal medicine market is being driven by the growing popularity of herbal teas and supplements, the emergence of boutique brands, and the integration of herbs into functional foods and beverages. Despite regulatory challenges, consumers are seeking natural alternatives for their healthcare needs, contributing to the market's growth.

Europe's integration of traditional herbal medicines into mainstream healthcare practices contributes significantly to market dominance. Many European countries have established regulatory frameworks that support the safe and effective use of herbal products, enhancing consumer confidence and regulatory compliance.

Europe's diverse array of herbal products spans three distinct categories: prescription drugs, over-the-counter (OTC) phytomedicines, and traditional herbal remedies. This variety caters to a broad spectrum of consumer needs and preferences, offering both regulated pharmaceutical-grade treatments and traditional remedies that have gained acceptance through generations of use. This diversity and regulatory framework contribute to Europe's robust and evolving herbal medicine market.

Will Increasing Consumer Awareness about the Benefits of Natural Remedies Enhance Adoption of Herbal Medicine in Asia Pacific?

The Asia Pacific herbal medicine market is experiencing rapid growth, driven by a long history of traditional medicine, increasing consumer awareness of natural remedies, and rising healthcare costs. Traditional practices in countries like India, China, and Japan contribute to the market's growth. The region's diverse range of botanical remedies and large consumer base contribute significantly to the global market.

China is a major exporter of herbal medicines and essential oils, followed by India and Indonesia. The Chinese traditional medicines industry is supported by favorable government policies, heavy research investments, and high consumer adoption. The Chinese Journal of Traditional Chinese Medicine reports that around USS 3.0 billion worth of traditional Chinese medicines are exported annually, and over 500 million practitioners consult, accounting for around 20% of Chinese outpatient visits.

The Asia Pacific herbal medicine market has grown due to a growing interest in traditional medicine practices like Traditional Chinese Medicine (TCM) and Ayurveda. These ancient healing methods emphasize the use of herbs and natural remedies for preventive care and treatment, leading to an increased demand for herbal supplements as consumers seek natural alternatives to synthetic drugs.

Competitive Landscape

The competitive landscape of the herbal medicine market is characterized by a diverse array of players ranging from established pharmaceutical companies to traditional medicine practitioners and smaller herbal product manufacturers. These entities compete based on factors such as product quality, efficacy, safety, pricing, distribution channels, and regulatory compliance. Market dynamics are shaped by increasing consumer demand for natural and alternative therapies, stringent regulatory standards, and ongoing research and development efforts to validate the efficacy of herbal remedies. The landscape is further influenced by partnerships, strategic alliances, and investments in technological advancements aimed at enhancing the formulation, production, and distribution of herbal medicines globally. Some of the prominent players operating in the herbal medicine market include:

Himalaya Wellness

Dabur India Ltd.

Schwabe Group

Tsumura & Co.

Blackmores Ltd.

Bio-Botanica, Inc.

Nature's Bounty Co.

Ricola AG

Young Living Essential Oils

Gaia Herbs

Nutraceutical International Corporation

Arizona Natural Products

Nature's Sunshine Products

Bioforce AG (A.Vogel)

Bach Flower Remedies Ltd.

Pukka Herbs Ltd.

MediHerb (a subsidiary of Integria Healthcare)

Weleda AG

Herbalife Nutrition Ltd.

Boiron

Latest Developments

In June 2023, Traditional Medicinals, a leading North American botanical wellness company, has introduced its Organic Lemon Ginger tea in Canada. This refreshing blend, made from organic herbal ingredients like lemon peel, ginger, hibiscus, and lemongrass, offers a zesty, sweet, and slightly spicy taste, suitable for hot or cold consumption.

In January 2023, Handard, an Indian traditional medicine manufacturer, has expanded its product range to include face washes, shampoos, and oral hygiene products.

In January 2022, Blackmores Ltd., an Australian natural health and dietary supplement company, has partnered with B28 e-commerce platform Udaan to distribute its multivitamin products in India, available at independent pharmacies through Udaan.

Herbal Medicine Market, By Category

• Form:
• Tablets and Capsules
• Powders
• Capsules and Tablets
• Syrups
• Extracts
• Source:
• Leaves
• Root and Barks
• Whole Plants and Fruits
• Distribution Channel:
• Hospital
• Retail Pharmacies
• E-Commerce
• Indication/Therapeutic Use:
• Digestive Health
• Respiratory Health
• Cardiovascular Health
• Joint and Musculoskeletal Health
• Stress Management/Mental Health
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Herbal Medicine Market, By Form

• Tablets and Capsules
• Powders
• Capsules and Tablets
• Syrups
• Extracts

5. Herbal Medicine Market, By Source

• Leaves
• Root and Barks
• Whole Plants and Fruits

6. Herbal Medicine Market, By Distribution Channel

• Hospital
• Retail Pharmacies
• E-Commerce

7. Herbal Medicine Market, By Indication/Therapeutic Use

• Digestive Health
• Immune Support
• Respiratory Health
• Cardiovascular Health
• Joint and Musculoskeletal Health
• Stress Management/Mental Health

8. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

9. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

10. Competitive Landscape

• Key Players
• Market Share Analysis

11. Company Profiles

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Novartis International AG
• Bayer AG
• Pfizer Inc.
• GlaxoSmithKline plc.
• Sanofi S.A.
• Merck & Co., Inc.
• Eli Lilly and Company
• Johnson & Johnson
• Nestle S.A.
• Herbalife International of America, Inc.
• Amway Corporation
• Nature's Sunshine Products, Inc.
• Dabur India Ltd.
• Himalaya Global Holdings Ltd.

12. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

13. Appendix

• List of Abbreviations
• Sources and References